Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Neven, P" or (type exact bookEditor and editor="Neven, P")

Add to list
- Journal Article
- A2
Molecular test algorithms for breast tumours

A Hébrant, K Punie, FP Duhoux, C Colpaert, G Floris, K Lambein, P Neven, M Berlière, R Salgado, M Chintinne, et al.

(2019) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 13(2). p.40-45
Add to list
- Journal Article
- A1
- open access
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials

JA Alberro, B Ballester, P Deulofeu, R Fabregas, M Fraile, JM Gubern, J Janer, A Moral, JL de Pablo, G Penalva, et al.

(2018) LANCET ONCOLOGY. 19(1). p.27-39
Add to list
- Journal Article
- A1
Coping with menopausal symptoms: an internet survey of Belgian postmenopausal women

Herman Depypere (UGent) , A Pintiaux, J Desreux, M Hendrickx, P Neven, E Marchowicz, V Albert, V Leclercq, S Van den Branden and S Rozenberg

(2016) MATURITAS. 90. p.24-30
Add to list
- Journal Article
- A2
The changing role of the axillary dissection in the treatment of breast cancer

A Smeets, B Carly, Veronique Cocquyt (UGent) , M Vanhoeij, C Bourgain, E Lifrange, Geert Villeirs (UGent) , M De Ridder, M Drijkoningen, J Lamote, et al.

(2012) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 6(3). p.87-95
Add to list
- Journal Article
- A1
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities

I Van Vlaenderen, JL Canon, Veronique Cocquyt (UGent) , G Jerusalem, JP Machiels, P Neven, M Nechelput, I Delabaye, M Gyldmark and Lieven Annemans (UGent)

(2009) ACTA CLINICA BELGICA. 64(2). p.100-112
Add to list
- Journal Article
- A4
VWOG-aanbevelingen bij de diagnose en chirurgische behandeling van het epitheliaal ovariumcarcinoom

P Van Dam, P Berteloot, G Vlaemynck, E De Jonge, P Neven, Rudy Van den Broecke (UGent) and F Amant

(2008) GUNAÏKEIA (NEDERLANDSE EDITIE). 13(6). p.184-189
Add to list
- Journal Article
- A4
VWOG-aanbevelingen bij de diagnose en chirurgische behandeling van het ovariumcarcinoom

G Vlaemynck, E De Jonge, P Berteloot, P Neven, Rudy Van den Broecke (UGent) , P Van Dam and F Amant

(2008) GUNAÏKEIA (NEDERLANDSE EDITIE). 13(6). p.190-193
Add to list
- Journal Article
- A4
VWOG-aanbevelingen betreffende de chirurgische behandeling van vulvaire intra-epitheliale neoplasie en invasief vulvacarcinoom

F Amant, P Berteloot, P Neven, Rudy Van den Broecke (UGent) , P Van Dam, G Vlamynck and P De Jone

(2008) GUNAÏKEIA (NEDERLANDSE EDITIE). 13(6). p.194-197
Add to list
- Journal Article
- A4
VWOG-aanbevelingen bij de diagnose en de chirurgische behandeling van het cervixcarcinoom

E De Jonge, P Berteloot, P Neven, Rudy Van den Broecke (UGent) , P Van Dam, G Vlaemynck and F Amant

(2008) GUNAÏKEIA (NEDERLANDSE EDITIE). 13(6). p.198-201
Add to list
- Journal Article
- A4
VWOG-aanbevelingen betreffende de chirurgische en pathologische kwaliteitscriteria bij borstkanker

P NEVEN, Rudy Van den Broecke (UGent) , P Berteloot, E De Jonge, P Van Dam, G Vlaemynck and F Amant

(2008) GUNAÏKEIA (NEDERLANDSE EDITIE). 13(6). p.202-205
Add to list
- Journal Article
- A1
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy

G Eelen, I Vanden Bempt, L Verlinden, M Drijkoningen, A Smeets, P Neven, MR Christiaens, Kathleen Marchal (UGent) , R Bouillon and A Verstuyf

(2008) ONCOGENE. 27(30). p.4233-4241
Add to list
- Journal Article
- A1
Fulvestrant (Faslodex (TM)) in advanced breast cancer: clinical experience from a Belgian cooperative study

P NEVEN, R PARIDAENS, G PELGRIMS, M MARTENS, A BOLS, J GOEMINNE, A VINDEVOGHEL, J DEMOL, B STRAGIER, J DE GREVE, et al.

(2008) BREAST CANCER RESEARCH AND TREATMENT. 109(1). p.59-65
Add to list
- Conference Paper
- C3
Cost-effectiveness analysis of letrozole vs. tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer: the Belgian perspective

J Kannon, M Berliere, Herman Depypere (UGent) , L Dirix, G Jerusalem, P Neven, R Pandaens and P Lecomte

(2007) BREAST. 16. p.S64-S65
Add to list
- Conference Paper
- C3
Adjuvant trastuzumab treatment in early stage breast cancer: Cost-effectiveness in the Belgian health care setting

I VAN VLAENDEREN, J CANON, Veronique Cocquyt (UGent) , G JERUSALEM, J MACHIELS, P NEVEN, M NECHELPUT, I DELABAYE, M GYLDMARK and Lieven Annemans (UGent)

(2007) VALUE IN HEALTH. 10(6).
Add to list
- Conference Paper
- C3
Extended adjuvant letrozole following five years of tamoxifen is cost-effective from a Belgian health care payer's perspective.

P LECOMTE, M BERLIERE, F BRANLE, F BUXANT, Herman Depypere (UGent) , L DIRIX, G JERUSALEM, F LIEBENS, P NEVEN and R PARIDAENS

(2006) ANNALS OF ONCOLOGY. 17. p.82-82
Add to list
- Conference Paper
- C3
Fulvestrant in heavily pretreated patients with advanced breast cancer: a Belgium cooperative study.

P NEVEN, R PARIDAENS, G PELGRIMS, M MARTENS, A BOLS, JC GOEMINNE, A VINDEVOGHEL, J DEMOL, B STRAGIER, J DE GREVE, et al.

(2006) BREAST CANCER RESEARCH AND TREATMENT. 100.
Add to list
- Journal Article
- A1
Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox I

P Neven, D Quail, F Marin, G Creatsas, Herman Depypere (UGent) , T Rechberger, S Liu-Leage, I Pavo, H Schmitt and T Nickelsen

(2005) MATURITAS. 52(2). p.87-101
Add to list
- Journal Article
- A2
Axillaire stagering met de schildwachtklier bij borstkanner : onze leercurve

E Lannoey, P Neven, F Amant, Jimmy Van den Eynden (UGent) , S Stroobant, A Van Steen, C Van Ongeval, R Drijkoningen, I Vergote and MR Christiaens

(2004) TIJDSCHRIFT VOOR GENEESKUNDE. 60(23). p.1699-1699
Add to list
- Miscellaneous
Eurolox 1: uterine safety of kilogest versus evista: preliminary results (vol 38, pg S83, 2002)

Herman Depypere (UGent) , P Neven, T Lunde, P Benedetti-Panici, TB Marinescu, T de Villiers, T Hillard, A Cano, E Peer, D Quail, et al.

(2003) EUROPEAN JOURNAL OF CANCER. 39(16). p.2412-2412
Add to list
- Conference Paper
- C3
Hormone receptor expression in Flemish patients with in situ and invasive primary breast cancer

Herman Depypere (UGent) , F DE PRINS, Petra De Sutter (UGent) , Amin Makar (UGent) , N SCHOCKAERT, W TJALMA, P VAN DAM, I VERGOTE and P NEVEN

(2002) EUROPEAN JOURNAL OF CANCER. 38.

Academic Bibliography

Molecular test algorithms for breast tumours

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials

Coping with menopausal symptoms: an internet survey of Belgian postmenopausal women

The changing role of the axillary dissection in the treatment of breast cancer

Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities

VWOG-aanbevelingen bij de diagnose en chirurgische behandeling van het epitheliaal ovariumcarcinoom

VWOG-aanbevelingen bij de diagnose en chirurgische behandeling van het ovariumcarcinoom

VWOG-aanbevelingen betreffende de chirurgische behandeling van vulvaire intra-epitheliale neoplasie en invasief vulvacarcinoom

VWOG-aanbevelingen bij de diagnose en de chirurgische behandeling van het cervixcarcinoom

VWOG-aanbevelingen betreffende de chirurgische en pathologische kwaliteitscriteria bij borstkanker

Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy

Fulvestrant (Faslodex (TM)) in advanced breast cancer: clinical experience from a Belgian cooperative study

Cost-effectiveness analysis of letrozole vs. tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer: the Belgian perspective

Adjuvant trastuzumab treatment in early stage breast cancer: Cost-effectiveness in the Belgian health care setting

Extended adjuvant letrozole following five years of tamoxifen is cost-effective from a Belgian health care payer's perspective.

Fulvestrant in heavily pretreated patients with advanced breast cancer: a Belgium cooperative study.

Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox I

Axillaire stagering met de schildwachtklier bij borstkanner : onze leercurve

Eurolox 1: uterine safety of kilogest versus evista: preliminary results (vol 38, pg S83, 2002)

Hormone receptor expression in Flemish patients with in situ and invasive primary breast cancer

Contents

Support

Contact